Articles

New study shows implementing tighter treatment goals for GDM does not improve birth weight in neonates, but may increase risk for earlier birth and clinician intervention.

Study focuses on score accuracy to improve prediction models for the better.

New study shows treating prediabetes risk for developing diabetes could reverse the disease before it starts.

MIDUS study looks at individual adverse childhood experiences and their impacts on future diabetes.

Will perceived quality of life be affected by increasing antidiabetes medication burden on the patient?

New study shows diuresis, canagliflozin use nearly doubled risk of complications.

In mid-November 2018, the U.S. Department of Health and Human Services finally released new physical activity guidelines (as a 2nd edition) to update their previous set from a decade before. Various activity guidelines for adults with diabetes have been updated several times in the interim, including a 2010 position statement on exercising with type 2 diabetes published jointly by the American College of Sports Medicine and the American Diabetes Association; a 2016 ADA position statement on exercise and physical activity for all types of diabetes; and a consensus statement on being active with type 1 diabetes published in The Lancet in 2017.

Diabetes in Control readers are being asked to participate in exclusive research that will provide new insights into what you think about insulin pumps and daily injections. Whether you’re a patient, a patient family member, medical professional or diabetes educator, we need to hear from you. Please take a few moments to take our survey and help our research. The survey takes only about 3 minutes, is completely anonymous, and lets you make your voice heard in analysis that can potentially influence the future of insulin delivery research and development.

The beta-cell preserving properties of short courses of metformin and insulin glargine evaluated in ever-growing population of patients who have diabetes.

Study assesses effect of new add-on therapy.